Literature DB >> 12731067

CD55/decay accelerating factor is part of the lipopolysaccharide-induced receptor complex.

Holger Heine1, Volker T El-Samalouti, Corinna Nötzel, Alexandra Pfeiffer, Arnd Lentschat, Shoichi Kusumoto, Gerd Schmitz, Lutz Hamann, Artur J Ulmer.   

Abstract

Recently, we described an 80-kDa lipopolysaccharide (LPS)-binding membrane protein to be identical to CD55 [decay accelerating factor (DAF)]. Here, we demonstrate that CD55 is able to contribute to lipopolysaccharide (LPS) signaling. Transfection of Chinese hamster ovary (CHO) cells with human CD55 resulted in a translocation of NF-kappa B after stimulation with LPS as well as with free lipid A. In addition, interaction of lipid A and CD55 was shown by co-immuno-precipitation of these molecules from CHO-CD55 cells after incubation with lipid A and anti-lipid A monoclonal antibody, as well as by fluorescence resonance energy transfer (FRET) analysis in human monocytes. The comparison of LPS-induced signaling pathways in CHO-CD55 and CHO-CD14 cells revealed that p38, JNK and ERK MAP kinases are activated upon LPS stimulation in both cell lines, and that the activation by LPS can be blocked at the level of Toll-like receptor 4. Finally, through FRET analysis we could demonstrate LPS-induced clustering of CD55 and CD11/CD18 in human monocytes. Our results imply a new functional role of CD55 as a member of a multimeric LPS receptor complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731067     DOI: 10.1002/eji.200323381

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

2.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

3.  Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.

Authors:  Stephen E Christmas; Claudia T de la Mata Espinosa; Deborah Halliday; Cheryl A Buxton; Joanne A Cummerson; Peter M Johnson
Journal:  Immunology       Date:  2006-09-26       Impact factor: 7.397

4.  Epithelial adhesion molecules and the regulation of intestinal homeostasis during neutrophil transepithelial migration.

Authors:  Ronen Sumagin; Charles A Parkos
Journal:  Tissue Barriers       Date:  2015-04-03

5.  BK channels regulate myometrial contraction by modulating nuclear translocation of NF-κB.

Authors:  Youe Li; Ramón A Lorca; Xiaofeng Ma; Alexandra Rhodes; Sarah K England
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

Review 6.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells.

Authors:  C B Huang; K A Emerson; O A Gonzalez; J L Ebersole
Journal:  Oral Microbiol Immunol       Date:  2009-10

Review 9.  Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.

Authors:  Eva M Pålsson-McDermott; Luke A J O'Neill
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

10.  Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses.

Authors:  Martha Triantafilou; Klaus Brandenburg; Shoichi Kusumoto; Koichi Fukase; Alan Mackie; Ulrich Seydel; Kathy Triantafilou
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.